Skip to main content
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
31.12
-1.00 (-3.11%)
At close: Mar 28, 2025, 4:00 PM
31.19
+0.07 (0.22%)
After-hours: Mar 28, 2025, 7:59 PM EDT

Moderna Revenue

In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%. Moderna had revenue of $966.00M in the quarter ending December 31, 2024, a decrease of -65.64%.

Revenue (ttm)
$3.24B
Revenue Growth
-52.75%
P/S Ratio
3.69
Revenue / Employee
$557,931
Employees
5,800
Market Cap
12.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.24B-3.61B-52.75%
Dec 31, 20236.85B-12.42B-64.45%
Dec 31, 202219.26B792.00M4.29%
Dec 31, 202118.47B17.67B2,200.25%
Dec 31, 2020803.00M743.00M1,238.33%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

MRNA News

More News